UC Davis and Elon Musk's company Neuralink are facing allegations that researchers mistreated monkeys that were being used to test Neuralink's brain-machine interface technology.

Nevro criticizes Medtronic's use of older, smaller European studies to support its recent FDA approval of spinal cord stimulation therapy for treating painful diabetic neuropathy.

Feinstein’s wireless stim device advances potential neuromodulation research and treatment options.

Quickly catch up on the latest medtech news from Medtronic, Acutus, Bausch + Lomb, and more.

The three-month results show meaningful pain relief using a lower-energy variation of the company's Differential Target Multiplexed Spinal Cord Stimulation therapy.

New stroke therapy device expands discussion of what is ‘meaningful’ recovery.

As with many other emerging technologies, brain-computer interface technology requires the right safeguards to protect consumers and ensure privacy, according to an IBM think tank.

A pilot study shows how a new tool can improve specific human brain functions related to self-control and mental flexibility.

A Delaware jury has ordered Nevro to pay Boston Scientific $20 million regarding the infringement of two patents for spinal cord stimulation technology.

LivaNova is expected to get its first look at the RECOVER data for difficult-to-treat depression later this year.